Eli Lilly and Company (LLY) News Today → Who are Nvidia’s New Silent Partners? (From Weiss Ratings) (Ad) Free LLY Stock Alerts $812.77 +4.91 (+0.61%) (As of 05/29/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 30 at 4:58 AM | americanbankingnews.comLilly Endowment Inc Sells 92,563 Shares of Eli Lilly and Company (NYSE:LLY) StockMay 30 at 12:22 AM | marketbeat.comComgest Global Investors S.A.S. Sells 46,650 Shares of Eli Lilly and Company (NYSE:LLY)Comgest Global Investors S.A.S. reduced its position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 5.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 826,438 sharMay 29 at 5:48 PM | finance.yahoo.comEli Lilly's Retevmo Gets FDA Accelerated Approval for Kids With RET-altered Thyroid Cancer, Solid TumorsMay 29 at 5:48 PM | finance.yahoo.comFDA Conditionally Approves Eli Lilly's Thyroid Cancer Drug For Pediatric Patients With Certain MutationsMay 29 at 4:34 PM | marketbeat.comEli Lilly and Company (NYSE:LLY) Major Shareholder Lilly Endowment Inc Sells 2,052 SharesEli Lilly and Company (NYSE:LLY - Get Free Report) major shareholder Lilly Endowment Inc sold 2,052 shares of Eli Lilly and Company stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $809.00, for a total transaction of $1,660,068.00. Following the completion of the transaction, the insider now directly owns 98,554,195 shares in the company, valued at $79,730,343,755. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Major shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.May 29 at 2:30 PM | marketbeat.comEli Lilly and Company (NYSE:LLY) Trading 0.7% Higher Eli Lilly and Company (NYSE:LLY) Stock Price Up 0.7%May 29 at 12:48 PM | finance.yahoo.comLilly, Amazon Pump Billions Into Indiana’s Industrial ResurgenceMay 29 at 6:15 AM | fool.comCould Eli Lilly Be the Next to Join the Trillion-Dollar Club?May 29 at 6:00 AM | americanbankingnews.comEli Lilly and Company (NYSE:LLY) Shares Down 0.1% May 29 at 6:00 AM | prnewswire.comLilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseasesMay 29 at 4:30 AM | insidertrades.comEli Lilly and Company (NYSE:LLY) Major Shareholder Lilly Endowment Inc Sells 92,563 SharesMay 29 at 12:36 AM | marketbeat.comEli Lilly and Company (NYSE:LLY) Stock Position Increased by Legacy Advisors LLCLegacy Advisors LLC boosted its position in Eli Lilly and Company (NYSE:LLY - Free Report) by 137.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,852 shares of the company's stock after purchasing an additMay 28 at 4:24 PM | marketbeat.comEli Lilly and Company (NYSE:LLY) Major Shareholder Sells $74,902,905.23 in StockEli Lilly and Company (NYSE:LLY - Get Free Report) major shareholder Lilly Endowment Inc sold 92,563 shares of the company's stock in a transaction that occurred on Friday, May 24th. The shares were sold at an average price of $809.21, for a total transaction of $74,902,905.23. Following the sale, the insider now owns 98,556,247 shares in the company, valued at $79,752,700,634.87. The sale was disclosed in a filing with the SEC, which is available at this link. Large shareholders that own 10% or more of a company's shares are required to disclose their transactions with the SEC.May 28 at 4:08 PM | theglobeandmail.comEli Lilly Bolsters Spending to Promote GLP-1sMay 28 at 4:08 PM | msn.com'Not Just A Weight Loss Story:' Eli Lilly CEO Thinks It's Possible To Meet BofA's $60B Revenue Projection From New Drug LaunchesMay 28 at 1:45 PM | marketbeat.comEli Lilly and Company (NYSE:LLY) Stock Price Down 0.5%Eli Lilly and Company (NYSE:LLY) Shares Down 0.5%May 28 at 10:00 AM | prnewswire.comLilly to Participate in Goldman Sachs 45th Annual Global Healthcare ConferenceMay 28 at 9:29 AM | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Eli Lilly & Co (LLY) and Veeva Systems (VEEV)May 28 at 8:41 AM | marketbeat.comLifeMD Can Surge on Its GLP-1 Offerings (LLY)LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a resultMay 28 at 4:39 AM | fool.comSoaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?May 27 at 10:55 PM | marketbeat.com3Chopt Investment Partners LLC Takes $2.03 Million Position in Eli Lilly and Company (NYSE:LLY)3Chopt Investment Partners LLC purchased a new position in Eli Lilly and Company (NYSE:LLY - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 3,477 shares of the company's stock, valued at approximately $2,027,000. Several other hMay 27 at 11:46 AM | marketbeat.comEli Lilly and Company (NYSE:LLY) Trading Down 0.1%Eli Lilly and Company (NYSE:LLY) Shares Down 0.1%May 26, 2024 | seekingalpha.comEli Lilly: Addressing Supply Challenges Should Accelerate GrowthMay 26, 2024 | finance.yahoo.comDow Jones Futures: Nvidia-Led Market Rally Narrows; 7 Stocks Near Buy PointsMay 26, 2024 | marketbeat.comIntech Investment Management LLC Purchases 8,183 Shares of Eli Lilly and Company (NYSE:LLY)Intech Investment Management LLC grew its position in Eli Lilly and Company (NYSE:LLY - Free Report) by 4.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 182,351 shares of the company's stock after buying an additional 8,183 shares during the period. Eli LillMay 26, 2024 | fool.comGot $500? 3 Pharma Stocks to Buy and Hold ForeverMay 25, 2024 | americanbankingnews.comEli Lilly and Company (NYSE:LLY) Stock Price Up 1.2%May 25, 2024 | cnbc.comHow digital health companies are capitalizing on the GLP-1 boomMay 25, 2024 | fool.com3 High-Flying Stocks That Could Soar Even MoreMay 25, 2024 | yahoo.comHolcomb, Eli Lilly announce additional $5.3 billion investment in LEAPMay 25, 2024 | marketbeat.comPrimecap Management Co. CA Has $12.94 Billion Holdings in Eli Lilly and Company (NYSE:LLY)Primecap Management Co. CA trimmed its position in Eli Lilly and Company (NYSE:LLY - Free Report) by 3.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 22,200,534 shares of the company's stock after selling 863,002 sharesMay 24, 2024 | finance.yahoo.comEli Lilly commits $5.3B to up weight-loss drug productionMay 24, 2024 | msn.comEli Lilly investment in Lebanon up to $9BMay 24, 2024 | msn.comEli Lilly Makes Largest Manufacturing Investment In Its History To Boost Production For Antidiabetic And Weight Loss MedsMay 24, 2024 | marketbeat.comEli Lilly and Company (NYSE:LLY) Trading 0.1% Higher Eli Lilly and Company (NYSE:LLY) Shares Up 0.1%May 24, 2024 | marketbeat.comEli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, MounjaroEli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually make more doses of its hot-selling weight-loss and diabetes treatments, Zepbound and MounjaroMay 24, 2024 | ft.comEli Lilly to invest extra $5.3bn in manufacturing site for weight loss drugsMay 24, 2024 | reuters.comLilly invests further $5.3 bln in new Indiana site as obesity drug demand soarsMay 24, 2024 | cnbc.comEli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supplyMay 24, 2024 | prnewswire.comLilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline MedicinesMay 24, 2024 | wsj.comEli Lilly to Spend $5.3 Billion to Make More Mounjaro, ZepboundMay 24, 2024 | investorplace.com7 Stocks to Buy if the Market Ends Up PlungingMay 24, 2024 | marketbeat.comEli Lilly and Company (NYSE:LLY) Shares Sold by Greylin Investment Management IncGreylin Investment Management Inc decreased its position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 12.4% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 7,425 shares of the company's stock after selling 1,050 shares during the periodMay 23, 2024 | prnewswire.comLilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual MeetingMay 23, 2024 | marketbeat.comEli Lilly and Company (NYSE:LLY) Trading Up 1.2%Eli Lilly and Company (NYSE:LLY) Trading Up 1.2%May 23, 2024 | msn.comSA Asks: Is Eli Lilly or Novo Nordisk a better investment?May 23, 2024 | investorplace.com3 Biotech Stocks to Buy on the Dip: May 2024May 23, 2024 | cnbc.comThis up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&AMay 23, 2024 | bizjournals.comDurham biotech, Eli Lilly ink billion-dollar deal aimed at cancer treatmentsMay 23, 2024 | finance.yahoo.comSurprise: Eli Lilly Is Racing Toward Yet Another Blockbuster Get Eli Lilly and Company News Delivered to You Automatically Sign up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter. Email Address BUY ALERT: Tiny tech play partners with US government (Ad)The Federal Reserve is rolling out a powerful new financial technology across the entire U.S. banking system. It's forecasted to grow 24,290% in the near future... Meaning, your bank is nearly certain to adopt it (if it hasn't already). Get the full story here while you can. Related VideosBiotech Boom: Stocks Skyrocketing & What's Next LLY Media Mentions By Week LLY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LLY News Sentiment▼0.560.80▲Average Medical News Sentiment LLY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LLY Articles This Week▼5635▲LLY Articles Average Week Get Eli Lilly and Company News Delivered to You Automatically Sign up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Johnson & Johnson News Today Merck & Co., Inc. News Today AbbVie News Today Pfizer News Today Bristol-Myers Squibb News Today Zoetis News Today Royalty Pharma News Today Jazz Pharmaceuticals News Today Perrigo News Today Corcept Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:LLY) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarGold Set to EXPLODE!Gold Safe ExchangeWrite this ticker symbol down…StocksToTradeWho are Nvidia’s New Silent Partners?Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eli Lilly and Company Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
